Targeting Nitric Oxide: Say NO to Metastasis

Utilizing targeted therapies capable of reducing cancer metastasis, targeting chemoresistant and self-renewing cancer stem cells, and augmenting the efficacy of systemic chemo/radiotherapies is vital to minimize cancer-associated mortality. Targeting nitric oxide synthase (NOS), a protein within the...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Tejaswini P., Glynn, Sharon A., Billiar, Timothy R., Wink, David A., Chang, Jenny C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183809/
https://www.ncbi.nlm.nih.gov/pubmed/36520504
http://dx.doi.org/10.1158/1078-0432.CCR-22-2791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183809/
https://www.ncbi.nlm.nih.gov/pubmed/36520504
http://dx.doi.org/10.1158/1078-0432.CCR-22-2791

Ejemplares similares